SILENCE THERAP. SP.ADR/1 (XRP2) — Tangible Net Worth Ratio
SILENCE THERAP. SP.ADR/1 (XRP2) has a Tangible Net Worth Ratio of 99.5% as of December 2025. This metric is calculated by deducting intangible assets (€288.00K) from net assets (€62.30 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore XRP2 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
SILENCE THERAP. SP.ADR/1 Tangible Net Worth Ratio (2021–2025)
This chart shows how SILENCE THERAP. SP.ADR/1's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 99.5%, reflecting net assets of €62.30 Million with intangible assets of €288.00K EUR. For live market cap and overall valuation, see XRP2 stock market capitalisation.
Annual Tangible Net Worth Ratio for SILENCE THERAP. SP.ADR/1 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for SILENCE THERAP. SP.ADR/1 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore SILENCE THERAP. SP.ADR/1 capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.5% | €62.30 Million | €288.00K | €131.44 Million | ▼ -0.2 pp |
| 2024 | 99.8% | €134.02 Million | €312.00K | €202.63 Million | ▲ +1.4 pp |
| 2023 | 98.4% | €21.99 Million | €362.00K | €119.45 Million | ▼ -0.2 pp |
| 2022 | 98.6% | €26.71 Million | €387.26K | €130.10 Million | ▼ -1.2 pp |
| 2021 | 99.7% | €11.51 Million | €32.39K | €129.83 Million | — |